Clinical Trials Directory

Trials / Completed

CompletedNCT02764307

Aerosol Delivery in Different Types of Nebulizers

Evaluation of Aerosol Delivery in Different Types of Nebulizers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Chang Gung University · Academic / Other
Sex
All
Age
20 Years – 25 Years
Healthy volunteers
Accepted

Summary

Background: Nebulizers design influences efficiency of aerosol delivery. Performance of nebulizers is commonly tested by breathing simulators with static parameters. However, breathing patterns vary in adults. Objectives: The purpose of this study was to evaluate drug deposition of different types of nebulizers testing with breathing patterns of healthy subjects.

Detailed description

Material and Methods The study was approved by Chang Gung Memorial Foundation Institutional Review Broad. Ten healthy subjects, aged 20.6±0.5 years, were recruited. Four nebulizers: 1. a constant jet nebulizer (Neb-easy, Galemed Corp., Taiwan); 2. a breath enhanced nebulizer (Pari LC plus, Pari Inc., Germany); 3. a manual-actuated nebulizer (A-T Neb, Atlantean Corporation, Taiwan); and 4. a breath-actuated nebulizer (AeroElipes, Trudell Medical Inc, Canada) were evaluated.

Conditions

Interventions

TypeNameDescription
DEVICEConstant jet nebulizerA constant jet nebulizer (Neb-easy, Galemed Corp., Taiwan) was tested with salbutamol sulfate powered by compressed gas flow at 6 L/min.
DEVICEBreath enhanced nebulizerA breath enhanced nebulizer (Pari LC plus, Pari Inc., Germany) was tested with salbutamol sulfate powered by compressed gas flow at 6 L/min.
DEVICEManual-actuated nebulizerA manual-actuated nebulizer (A-T Neb, Atlantean Corporation, Taiwan) was tested with salbutamol sulfate powered by compressed gas flow at 6 L/min.
DEVICEBreath-actuated nebulizerA breath-actuated nebulizer (AeroElipes, Trudell Medical Inc, Canada) was tested with salbutamol sulfate powered by compressed gas flow at 6 L/min.

Timeline

Start date
2015-10-01
Primary completion
2016-10-01
Completion
2016-12-01
First posted
2016-05-06
Last updated
2017-02-01

Source: ClinicalTrials.gov record NCT02764307. Inclusion in this directory is not an endorsement.